Page 33 - PharmBio2122_25June21
P. 33

                                                                                                                                                                                                                                          SINGAPORE PHARMBIO GUIDE 2021/2022
                                                                                                                                                                                                                   enables the holder to remain in Singapore for up to six months in between jobs to evaluate new employment opportunities. PEP is however only available to existing Employment Pass holders who earn a minimum monthly salary of S$12,000 or overseas-based professionals earning a monthly income of at least S$18,000.
For details about the PEP and other employment passes, please refer to the Ministry of Manpower’s website (www. mom.gov.sg).
A new Tech.Pass programme was also launched in 2020 to attract foreign talents skilled in establishing technology companies to contribute towards the development of Singapore’s technology ecosystem. Valid for an initial period of 2 years, the Tech.pass enables holders to start, operate, consult for, invest in, or work in a local tech company or teach at a local Institute of Higher Learning. More info on the programme may be found at EDB’s website (www.edb.gov.sg).
QUALITY AND STANDARDS
Good Laboratory Practice (GLP) Programme
Singapore is the first Asian non-OECD member state to be accepted into the Organisation for Economic Co-operation and Development (OECD) Mutual Acceptance of Data framework. With this OECD-MAD status, data generated by local testing facilities that comply with
the OECD Principles of Good Laboratory Practice (GLP) will be simultaneously accepted by over 30 OECD and non-OECD member states.
The GLP compliance Monitoring programme is now managed by the Singapore Accreditation Council (SAC), a body operating under Enterprise Singapore. SAC manages the registration of GLP facilities and conducts periodical surveillance inspections to verify compliance status of certified facilities. A list of GLP certified facilities in Singapore may be found on SAC’s website (www.sac- accreditation.gov.sg). A number of them are testing labs serving the Biomedical Sciences industry in Singapore.
In addition, SAC offers schemes to accredit various inspection and management system certification bodies as well as laboratories conducting tests, calibrations and measurements. Bodies offering certification services may also be accredited by SAC so as to gain recognition for their competency in internationally recognised standards. SAC
is also a signatory of a number of multi- lateral Mutual Recognition Arrangement (MRAs) which promotes cross-border recognition of accredited bodies. A list of the various signed MRAs may be found on the SAC’s website.
GROWTH OF
THE PHARMACEUTICAL
MANUFACTURING INDUSTRY
The pharmaceutical and biopharmaceutical manufacturing sector has evolved over the past decade to become a cornerstone of the Singapore biomedical sciences industry. Today, Singapore is recognised as a world class hub for pharmaceutical and biopharmaceutical manufacturing, hosting the manufacturing operations of many of the world’s leading multinational firms (Table 1). Collectively, these companies have invested over S$5 billion to set up their local manufacturing facilities. They now account for a sizable portion of Singapore’s total pharmaceutical exports, contribute close to S$18 billion in output annually, and have created over 6,000 jobs opportunities.
  27



















































































   31   32   33   34   35